The global abdominal aortic aneurysm drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Abdominal aortic aneurysm is defined as a medical condition that leads to bulging or swelling in the aorta, the main blood vessel that runs from the heart down through the chest and tummy. An abdominal aortic aneurysm may prove to be risky if it is not detected in its early stage. Abdominal aortic aneurysm can get bigger over time and could even rupture, resulting into life-threatening bleeding. Thus, as a treatment measure for this condition, abdominal aortic aneurysm drugs are recommended to the patients. Hence, the growing demand for these drugs is likely to spur the market growth. Although surgery is the most probable treatment for the condition, however, medication is also provided which aids the surgery process to some extent. 

The rise in consumption of tobacco and increasing number of smokers are the major factor behind the growth of this market. Another driving factor for these dugs include the rising prevalence of hypertension. Although men are found to be at more risk for such diseases due to the sedentary lifestyles and unhealthy eating habits. The major factor restraining the growth of the market is the side effects associated with the drugs. 

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Drug Class

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Eli Lilly and Co., and AstraZeneca plc, among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Abdominal Aortic Aneurysm Drug Market Report by Segment

By Drug Class

• ?-blockers

• Angiotensin-Converting Enzyme Inhibitor (ACE inhibitors)

• Angiotensin-Receptor Blocker (ARB)

• Doxycycline

• Others

By Application

• Hospital

• Clinic

• Others

Global Abdominal Aortic Aneurysm Drug Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa